autosomal dominant polycystic kidney disease adpkd one common lifethreatening inherited human disorders common hereditary kidney associated large interfamilial intrafamilial variability explained large extent genetic heterogeneity modifier also common inherited cystic kidney diseases group disorders related distinct pathogenesis characterized development renal cysts various extrarenal manifestations case adpkd include cysts organs liver seminal vesicles pancreas arachnoid membrane well abnormalities intracranial aneurysms dolichoectasias aortic root dilatation aneurysms mitral valve prolapse abdominal wall patients adpkd eventually develop end stage kidney disease require dialysis kidney adpkd estimated affect least one every individuals worldwide making disease common inherited kidney disorder diagnosed prevalence incidence global among clinical presentation arecitation needed signs symptoms adpkd often develop years adpkd genetically heterogeneous two genes identified chromosome region around cases around several genetic mechanisms probably contribute phenotypic expression although evidence exists twohit mechanism germline somatic inactivation two pkd alleles explaining focal development renal hepatic haploinsufficiency likely account vascular manifestations additionally new mouse models homozygous hypomorphic alleles demonstration increased renal epithelial cell proliferation mice suggest mechanisms twohit hypothesis also contribute cystic large interfamilial intrafamilial variability occurs individuals mutations kidney failure age years whereas individuals mutations adequate renal function age mean age onset endstage renal disease years years significant intrafamilial variability observed severity renal extrarenal manifestations points genetic environmental modifying factors may influence outcome adpkd results analysis variability renal function monozygotic twins siblings support role genetic modifiers estimated variance age esrd could due heritable modifying parents likely children show severe disease studies parentchild many patients adpkd kidney dysfunction clinically apparent years however increasing body evidence suggests formation renal cysts starts cysts initially form small dilations renal tubules expand form fluidfilled cavities different factors suggested lead cystogenesis include germline mutation one polycystin gene alleles somatic second hit leads loss normal allele third hit renal insult triggers cell proliferation injury due numerous similarities pathophysiology adpkd pathophysiology renal response injury adpkd described state aberrant persistent activation renal injury response progression disease continued dilation tubules increased cell proliferation fluid secretion separation parental tubule lead formation adpkd together many diseases present renal cysts classified family diseases known epithelial cells renal tubules including segments nephron collecting ducts exception intercalated cells show presence single primary apical protein encoded gene present cilia thought sense flow large extracellular domains activating calcium channels associated product gene result genetic setting adpkd explained genetics subsection epithelial cell proliferation fluid secretion lead cystogenesis two hallmark features early stages cystogenesis cysts attached parental renal tubules derivative glomerular filtrate enters cysts expand approximately mm diameter cyst closes parental tubule fluid enter cysts transepithelial secretion turn suggested increase due secondary effects increased intracellular concentration cyclic amp clinically insidious increase number size renal cysts translates progressive increment kidney studies led mayo clinic professionals established total kidney volume tkv large cohort adpkd patients mean increase three years per year natural course disease among important novel findings extensively studied first usually diagnosis adpkd initially performed renal imaging using ultrasound ct scan however molecular diagnostics necessary following situations definite diagnosis required young individuals potential living related donor affected family equivocal imaging patients negative family history adpkd potential phenotypic overlap several kidney cystic families affected earlyonset polycystic kidney disease since cases hypomorphic alleles andor oligogenic inheritance patients requesting genetic counseling especially couples wishing preimplantation genetic findings large echogenic kidneys without distinct macroscopic cysts infantchild risk adpkd diagnostic absence family history adpkd presence bilateral renal enlargement cysts without presence hepatic cysts absence manifestations suggestive different renal cystic disease provide presumptively definite evidence diagnosis cases intracranial aneurysms associated sign adpkd screening recommended patients family history intracranial molecular genetic testing linkage analysis direct mutation screening clinically available however genetic heterogeneity significant complication molecular genetic testing sometimes relatively large number affected family members need tested order establish one two possible genes responsible within family large size complexity genes well marked allelic heterogeneity present obstacles molecular testing direct dna analysis sensitivity testing nearly patients adpkd age years older younger patients mutations criteria sensitive patients mutations younger age needed adult polycystic kidney diagram autosomal dominant polycystic disease normal kidney inset comparison abdominal ct scan adult autosomal dominant polycystic kidney disease extensive cyst formation seen kidneys cysts liver well coronal plane currently pharmacological treatment available adpkd consists reducing speed gain total kidney volume tkv vasopressin receptor antagonists ie tolvaptan treatment halt reverse disease progression patients still progress towards renal failure palliative treatment modalities involve symptomatic medications nonopioid opioid analgesics abdominalretroperitoneal pain options analgesicresistant pain include simple complex surgical procedures ie renal cyst aspiration cyst decortication renal denervation nephrectomy result complications inherent surgerycitation needed recent research suggests ketogenic dietary interventions beneficially affect progression symptoms individuals mild weight loss favorably affects indicating benefit dietary lifestyle changes japan first country world approve pharmacological treatment followed canada europe approved drug tolvaptan adpkd patients beginning usa fda approved use tolvaptan treatment adpkd tolvaptan aquaretic drug vasopressin receptor preclinical studies suggested molecule camp could involved enlargement adpkd studies rodents confirmed role vasopressin increasing levels camp kidney laid basis conduction clinical data consortium radiologic imaging studies polycystic kidney disease crisp led mayo clinic showed total kidney volume tkv predicted risk developing chronic kidney disease patients tempo trial enrolled patients sites worldwide evaluated tkv primary endpoint test efficacy tolvaptan adpkd study showed significant decrease ratio tkv increase deterring renal function decline adpkd patients treatment however laboratory test results regarding liver function appeared elevated percentage patients enrolled study approval drug either delayed regulatory agencies case us altogether research using adpkd mouse models showed mild food restriction strongly improved disease mechanism shown involve metabolic state ketosis beneficial effects could produced timerestricted feeding acute fasting ketogenic diet supplementation ketone betahydroxybutyrate mouse rat cat models ketogenic diet regimen halted disease progression led partial reversal renal cystic disease rat metabolic state ketosis may beneficial adpkd renal cyst cells adpkd metabolic defect similar warburg effect cancer makes highly dependent glucose unable metabolize fatty acids consistent serum glucose levels positively correlate faster disease progression adpkd also individuals adpkd type diabetes significantly larger total kidney volume tkv adpkd overweight obesity associate faster progression earlystage retrospective case series study showed adpkd disease symptoms including pain hypertension renal function improved among patients implemented ketogenic diets average duration dietary intake sodium associated worse renal function decline limiting sodium intake generally recommended patients dietary protein intake found correlate adpkd increased water intake thought beneficial adpkd generally underlying beneficial mechanism increased water intake may related effects vasopressin receptor may due suppression harmful microcrystal formation renal tubules dilution solutes calcium oxalate calcium phosphate uric dietary intake oxalate inorganic phosphate shown accelerate pkd disease progression several rodent low levels urinary citrate natural antagonist formation harmful crystals kidney tubules shown associate worse disease progression adpkd chronic pain patients adpkd often refractory conservative noninvasive treatments nonopioid analgesics conservative interventions first used opioid analgesics considered pain continues surgical interventions target renal hepatic cysts directly address cause pain surgical options including renal cyst decortication renal denervation aspiration ethanol sclerotherapy performed treatment symptomatic simple renal cysts impractical advanced patients multiple procedure consists percutaneous insertion needle identified cyst ultrasound guidance subsequent draining contained liquid sclerotherapy used avoid liquid reaccumulation occur cyst result symptom laparoscopic cyst decortication also referred marsupialization consists removal one kidney cysts laparoscopic surgery cysts punctured outer wall larger cysts excised care incise renal procedure useful pain relief patients adpkd usually indicated earlier cyst aspiration confirmed cyst decorticated responsible nonrandomised controlled trials conducted showed patients symptomatic simple renal cysts recurrence symptoms initial response simple aspiration could safely submitted cyst decortication mean painfree life months laparoscopic decortication presents recurrence rate renal cysts compared recurrence rate obtained novel treatment specifically chronic pain experienced many adpkd celiac plexus involves chemical ablation celiac plexus cause temporary degeneration targeted nerve fibers nerve fibers degenerate causes interruption transmission nerve signals treatment successful provides significant pain relief period ranging days year procedure may repeated affected nerves healed pain many adpkd patients experience symptomatic sequelae consequence disease cyst hemorrhage flank pain recurrent infections nephrolithiasis symptoms mass effect ie early satiety nausea vomiting abdominal discomfort enlarged cases nephrectomy required due intractable symptoms course preparing kidney transplantation native kidneys found impinge upon true pelvis preclude placement donor additionally native nephrectomy may undertaken presence suspected malignancy renal cell carcinoma rcc two three times likely adpkd population endstage kidney disease eskd eskd patients without although indications nephrectomy adpkd may related kidney size decision proceed native nephrectomy often undertaken individual basis without specific reference kidney size two modalities dialysis used treatment adpkd patients peritoneal dialysis epidemiological data shows adpkd affects patients undergoing hemodialysis europe united peritoneal dialysis usually contraindicated adpkd patients large kidney liver volumes due expected physical difficulties procedure possible however difference seen longterm morbidity hemodialysis peritoneal dialysis kidney transplantation accepted preferred treatment adpkd patients among american patients kidneytransplant waiting list december listed due cystic kidney disease renal transplants performed done patients cystic kidney disease deceased donors living adpkd patients gradual cyst development expansion result kidney enlargement course disease glomerular filtration rate remains normal decades kidney function starts progressively deteriorate making early prediction renal outcome crisp mentioned treatment section contributed build strong rationale supporting prognostic value total kidney volume tkv adpkd tkv evaluated mri increases steadily higher rate kidney enlargement correlated accelerated decline gfr patient heightadjusted tkv httkv mlm predicts development stage chronic kidney disease within besides tkv httkv estimated glomerular filtration rate egfr also tentatively used predict progression analysis ct mri scans patients adpkd treated mayo translational polycystic kidney disease center irazabal colleagues developed imagingbased classification system predict rate egfr decline patients prognostic method patients divided five subclasses estimated kidney growth rates according agespecific httkv ranges delineated crisp decline egfr years following initial tkv measurement significantly different five patient subclasses subclass rapid common causes death patients adpkd various infections ruptured berry aneurysm coronaryhypertensive heart disease httpsenwikipediaorgwikiautosomaldominantpolycystickidneydisease